Skip to main content
Caplight Logo









Ensemo

Ensemo

Private
TullnFrontier & Industrial Techhttps://ensemo.com

Last Round

Accelerator

Mar 2, 2026

Total Funding Raised

$2.77M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Ensemo operates in Frontier & Industrial Tech and is based in Tulln. Its latest recorded funding round was an Accelerator round in March 2026.

Ensemo is an agricultural technology company that has developed a patented technology, SeedJection™, which injects living microorganisms directly into seeds to enhance performance and support plant health with reduced chemical dependence.

Sector

Frontier & Industrial Tech

Verticals

Biotechnology, Biotech Equipment, Clean Manufacturing

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Ensemo Comparables

Compare Ensemo with similar companies based on industry and business-model similarity.

Ensemo comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sinochem Holdings Corporation Ltd.
68%
Bayer AG
67%
CropBiome
66%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Ensemo Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorMar 2, 2026
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Ensemo Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 18, 2026

    Grew 38% QoQ from 8 to 11 employees.

  • Apr 16, 2026

    Monthly visitors increased 34% MoM, reaching 2.2K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Ensemo Filings

Explore SEC and related filing metadata, where available.

Ensemo filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Ensemo's valuation, stock price, and market status.

Is Ensemo a public or private company?

Ensemo is a private company.

What is the current stock price of Ensemo?

Ensemo is a private company, so its shares have no public market price. Caplight tracks Ensemo's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Ensemo worth (valuation)?

Valuation information for Ensemo is not publicly available.

Can I buy Ensemo stock?

Ensemo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Ensemo's last funding round?

Ensemo's most recent funding round was Accelerator on March 2, 2026.

Who are the main investors in Ensemo?

Key investors in Ensemo include European Innovation Council Fund, Austria Wirtschaftsservice, FFG Austrian Research Promotion Agency.

Will Ensemo IPO soon?

No public IPO plans have been announced for Ensemo.

How can I track Ensemo secondary market activity?

Caplight tracks bids, offers, and trades in Ensemo's shares on secondary markets.

Firmographic Details

HeadquartersTulln
Employee Range8
Year Founded2021
Last FundingMar 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?